Antibody developer XO1, backed by a Johnson & Johnson-backed fund, has been acquired by another Johnson & Johnson subsidiary, Janssen Parmaceuticals.

Hearst and Amazon both exited the revenue management company after it was acquired by AppNexus, which will integrate its technology into its own platform.

Pfizer-backed Cellectis, which is developing cancer treatments, will issue 3.5 million shares and could raise about $129m.

Pulmatrix, an inhaled drug developer that had raised $65m in venture funding, will be acquired by publicly-listed Ruthigen in an all-share deal.

Seachaid Pharmaceuticals-backed Cidara, which is developing therapies to treat fungal infections, has raised $74m in the past two years.

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.

Salesforce-backed internet of things company 2lemetry has been bought by online retailer Amazon for an undisclosed sum.

Johnson & Johnson-backed cancer drug developer Aduro has filed for an initial public offering, following a $51.4m series D round in January.

Online marketplace Lamido will be shut down and absorbed into e-commerce portal Lazada in a bid to consolidate Rocket Internet's Southeast Asian activities.

The corporate-backed venture firm has upped its stake in Delivery hero to 39% and has contributed to a $110m round raised by FoodPanda.